Sign in

    LyondellBasell Industries NV (LYB)

    Q1 2025 Earnings Summary

    Reported on Apr 25, 2025 (Before Market Open)
    Pre-Earnings Price$59.25Last close (Apr 24, 2025)
    Post-Earnings Price$57.55Open (Apr 25, 2025)
    Price Change
    $-1.70(-2.87%)
    • Strong circular plastics growth: LYB’s circular plastics volumes have historically grown around 57% per year—even exceeding 60% growth in the prior year—and the APS transformation is driving double-digit growth despite challenging markets.
    • Robust shareholder returns: The company has delivered a 14-year track record of dividend increases and continues to execute opportunistic share buybacks, reinforcing investor value through disciplined capital allocation and cash management.
    • Attractive capital projects: Investments in projects like Flex 2, with an expected IRR in the mid-teens, and ongoing MoReTec developments underscore LYB’s commitment to growing and upgrading its core, positioning it for long‐term profitability.
    • Trade and tariff risks: Rumors of heavy tariffs on U.S. feedstocks—including potential rates around 126%—could disrupt trade flows and negatively impact margins and sales volumes in key markets.
    • Weakening demand and slower investment: Reduced licensing sales for circular plastics and indications that brand owners are slowing their pace of capacity and new product investments suggest potential headwinds in revenue growth and project pipeline.
    • Operational disruptions impacting margins: Multiple operational challenges this quarter—such as planned and unplanned maintenance, turnarounds, and weather-related outages (e.g., winter storm impacts)—have already compressed EBITDA and add uncertainty to margin recovery.
    MetricYoY ChangeReason

    Revenue

    ~19–20% decline in Q1 2025 versus Q4 2024

    Revenue dropped from $9,497 million in Q4 2024 to approximately $7,528–$7,677 million in Q1 2025, primarily driven by lower sales volumes and margin pressures that were more favorable in the previous period. Factors such as operational challenges and seasonal demand fluctuations exacerbated the decline compared to recent quarters.

    U.S. Revenue

    39% decline in Q1 2025 versus Q4 2024

    U.S. revenue fell from $4,724 million in Q4 2024 to $2,855 million in Q1 2025, indicating significant regional underperformance likely caused by lower demand or operational disruptions in the U.S. market relative to the previous quarter’s stronger performance.

    Mexico Revenue

    Dramatic increase in Q1 2025 versus Q4 2024

    Mexico revenue surged from $38 million in Q4 2024 to $409 million in Q1 2025, signifying a strong regional divergence. This improvement could be attributed to better market conditions or pricing realignments in Mexico compared to the previous period.

    Operating Income

    Declined sharply from $802 million (Q3 2024) to $114 million (Q1 2025)

    Operating income contracted significantly, reflecting severe margin compression. Compared to the healthier margins in earlier periods, Q1 2025 was impacted by increased cost pressures and a cost of sales nearly equaling revenue, suggesting that lower sales volumes and rising costs overpowered any operational efficiencies achieved in prior quarters.

    Net Income

    Fell from $573 million in Q3 2024 to $177 million in Q1 2025

    Net income dropped markedly, mirroring the decline in operating income. The substantial fall—from $573 million to $177 million—highlights how lower revenues and narrowed margins from increased cost of sales and operational disruptions negatively affected profitability relative to the previous period.

    Cost of Sales

    Approached revenue levels in Q1 2025

    Cost of sales amounted to $7,128 million in Q1 2025, nearly matching the revenue figures. This situation leaves a very narrow gross margin compared to previous periods, indicating that rising production or input costs were not offset by pricing improvements, further squeezing profitability.

    Cash and Cash Equivalents

    Reduced from $3,375 million at end FY 2024 to $1,867 million in Q1 2025

    Cash and cash equivalents dropped sharply by over 44%, driven by deteriorated operating cash flows, increased financing outflows (notably $433 million in dividends and $110 million in share repurchases), and seasonal or one-off working capital changes. These factors contrast with the stronger liquidity position at the end of FY 2024.

    MetricPeriodPrevious GuidanceCurrent GuidanceChange

    Operating Rates – Intermediates & Derivatives Segment

    Q1 2025

    80%

    no current guidance

    no current guidance

    Operating Rates – Olefins & Polyolefins Americas Segment

    Q1 2025

    80%

    no current guidance

    no current guidance

    Operating Rates – Olefins & Polyolefins Europe, Asia and International Segment

    Q1 2025

    75%

    no current guidance

    no current guidance

    EBITDA Impact – Lost Volumes

    Q1 2025

    $45 million

    no current guidance

    no current guidance

    EBITDA Impact – Turnaround

    Q1 2025

    $190 million

    no current guidance

    no current guidance

    Market Outlook – Seasonal Demand

    Q1 2025

    Modest seasonal demand improvements

    no current guidance

    no current guidance

    Market Outlook – European Market

    Q1 2025

    Rising energy costs with some seasonal recovery

    no current guidance

    no current guidance

    Market Outlook – Asia

    Q1 2025

    Slow but steady improvements in volumes and margins

    no current guidance

    no current guidance

    Capital Expenditures (CapEx)

    FY 2025

    $1.9 billion

    no current guidance

    no current guidance

    Effective Tax Rate

    FY 2025

    17%

    no current guidance

    no current guidance

    EBITDA – Technology Segment

    Q2 2025

    no prior guidance

    Similar to Q1 2025 EBITDA of $52 million

    no prior guidance

    Operating Rates – Olefins & Polyolefins Americas Segment

    Q2 2025

    no prior guidance

    85% utilization

    no prior guidance

    Operating Rates – Olefins & Polyolefins Europe, Asia and International Segment

    Q2 2025

    no prior guidance

    75% utilization

    no prior guidance

    Operating Rates – Intermediates & Derivatives Segment

    Q2 2025

    no prior guidance

    85% utilization

    no prior guidance

    Seasonal Demand – Intermediates & Derivatives Segment

    Q2 2025

    no prior guidance

    Improvement in seasonal demand with enhanced oxyfuels margins

    no prior guidance

    Demand Outlook – Advanced Polymer Solutions Segment

    Q2 2025

    no prior guidance

    Expected growth in APS volumes despite challenged automotive demand

    no prior guidance

    Seasonal Demand – General Market Outlook

    Q2 2025

    no prior guidance

    Expected seasonal demand improvements

    no prior guidance

    Feedstock Costs – General Market Outlook

    Q2 2025

    no prior guidance

    Lower costs expected to provide tailwinds

    no prior guidance

    Trade Policy Volatility – General Market Outlook

    Q2 2025

    no prior guidance

    Anticipated near-term trade disruptions

    no prior guidance

    European Market – General Market Outlook

    Q2 2025

    no prior guidance

    Margin pressures expected to ease due to lower feedstock costs

    no prior guidance

    Oxyfuels Margins – General Market Outlook

    Q2 2025

    no prior guidance

    Summer driving season expected to support improved gasoline crack spreads

    no prior guidance

    TopicPrevious MentionsCurrent PeriodTrend

    Margin Improvement Strategies

    In Q4 2024, discussions focused on VEP, strategic initiatives, and circular & low‐carbon solutions driving margin uplift. In Q2 2024, the emphasis was on portfolio upgrades, feedstock optimization, and the VEP’s contribution to improved margins.

    Q1 2025 emphasized seasonal demand improvements, a comprehensive set of initiatives including the CIP and continued executing of the VEP, along with regional adjustments to improve margins.

    Consistent focus on enhancing margins with a broader regional focus and improved sentiment towards operational optimization.

    Capital Investments and Strategic Projects

    Q4 2024 highlighted disciplined capital spending with a mix of sustaining investments, strategic projects (including CLCS and divestitures), and key acquisitions. Q2 2024 detailed capex discipline, divestitures like the EO&D business, and strategic ventures such as the NATPET joint venture.

    Q1 2025 reiterated a moderate capex approach with continued prioritization of major projects like MoReTec 1 and Flex 2, and a clear cash improvement plan while maintaining investment discipline.

    Steady approach with continued commitment to strategic projects and a disciplined capital allocation mindset, ensuring focus on high-priority investments.

    Operational Disruptions and Maintenance Turnarounds

    In Q4 2024, there were discussions of major planned turnarounds at Channelview and a structured refinery shutdown, while Q2 2024 focused on hurricane impacts, planned maintenance at European crackers, and moderate downtime events.

    Q1 2025 described multiple disruptions, including a significant Channelview turnaround with a ~$200 million impact, unplanned outages (e.g. Lake Charles JV) and challenges from Winter Storm Enzo.

    Increased operational challenges are evident in Q1 2025, though the topic remains consistently important and closely monitored.

    Demand Trends and Market Recovery

    Q4 2024 discussions centered on modest seasonal improvements, recovery in domestic polyethylene demand, and steady growth in propylene oxide segments. In Q2 2024, there was strong focus on polyolefins demand, record exports, and clear seasonal patterns supporting recovery.

    Q1 2025 highlighted regional differences with positive signals in the Americas, subdued sentiment in China, and cautious outlooks overall—anticipating seasonal improvements but acknowledging persisting market uncertainties.

    Mixed sentiment persists with recovery signals in key regions, yet regional disparities and headwinds remain a concern.

    Feedstock and Energy Cost Dynamics

    Q4 2024 emphasized the pressure from higher ethane and natural gas prices and their negative impact on margins, while Q2 2024 noted lower costs in North America and the use of advantaged LPG feedstocks in Europe.

    Q1 2025 continued to see higher feedstock costs impacting margins in the Americas, while highlighting tailwinds from lower feedstock costs in Europe along with caution over potential tariff impacts.

    Cautious outlook remains as regional dynamics differ; sentiment is mixed with optimism in some regions offset by rising costs elsewhere.

    Trade and Tariff Risks

    In Q4 2024, tariff risks were briefly mentioned in the context of potential impacts on affordability and global trade. Q2 2024 did not provide any discussion on this topic.

    Q1 2025 offered an in‐depth discussion on trade and tariff risks, stressing global supply network resilience, U.S. feedstock tariff concerns, and potential headwinds for segments like APS due to cascading trade uncertainties.

    Increased focus on trade and tariff risks in Q1 2025 marks a return to detailed analysis, after being absent in Q2 2024, pointing to growing external pressures.

    Circular Plastics Growth

    Q4 2024 stressed robust CLCS growth with 65% volume increases, strategic investments in MoReTec facilities, and regulatory drivers such as PPWR. In Q2 2024, emphasis was on MoReTec technology progress at the Ferrara plant and transformational plans at the Houston refinery.

    In Q1 2025, circular plastics continued to show double-digit volume growth, supported by high market demand and key investments in chemical recycling projects, with regulatory developments reinforcing the growth narrative.

    Consistent robust growth with strong market and regulatory support, underpinning the long-term potential of circular plastics initiatives.

    Shareholder Returns and Capital Allocation

    Q4 2024 focused on record dividend increases (14 consecutive years), significant share repurchases, and a total of $1.9 billion returned; Q2 2024 highlighted strong cash conversion, high free cash flow returns, and continued dividend hikes.

    Q1 2025 reported maintaining strong returns with $2.1 billion total over 12 months, disciplined capex reductions, and a consistent focus on a balanced capital allocation strategy, including targeted reductions in growth capex.

    Steady and strong commitment to returning capital to shareholders through disciplined spending and consistent dividend growth remains a top priority.

    European Operations and Cost Challenges

    Q4 2024 mentioned capacity rationalization, high energy costs, and an ongoing strategic review to address operational challenges in Europe, while Q2 2024 discussed asset reviews, planned maintenance at German sites, and optimization of European feedstock usage.

    Q1 2025 provided a deeper look into European portfolio reshaping—including asset closures, targeted fixed cost reductions (~$300 million savings), and a strategic review that is expected to boost margins beyond 21%—while noting challenges from high energy costs and regulatory burdens.

    Enhanced focus on streamlining European operations with strategic reviews and cost reductions, aiming for significant margin improvements amid ongoing challenges.

    1. EBITDA Outlook
      Q: What are current trough EBITDA expectations?
      A: Management expects that after recent turnarounds, trough EBITDA will be adjusted upward, and mid‐cycle EBITDA margins could improve from 18% to above 21%, reflecting a modest Q1 rebound despite challenging conditions.

    2. European Assets
      Q: How will asset divestitures affect EBITDA?
      A: The divestiture of the 5 European assets is seen as a strategic portfolio upgrade, which should enhance overall margins and push mid‐cycle EBITDA above 21% from previous levels around 18%.

    3. Capital Spending
      Q: What is the 2025–26 CapEx outlook?
      A: Capital expenditure is expected to remain disciplined at about $1.8 billion, including a fixed maintenance spend of $1.2 billion, while growth projects such as Flex 2, MoReTec 1, and engineering for MoReTec 2 continue on a measured course.

    4. Capital Preservation
      Q: What about buybacks and dividend increases?
      A: Management highlighted a strong balance sheet and a shareholder-friendly approach, having executed roughly $110 million in repurchases and maintaining a robust, long-standing commitment to growing dividends.

    5. Tariff Impacts
      Q: How will tariffs impact U.S. feedstocks?
      A: While market dynamics remain fluid with rumors of tariffs on ethane, management believes that anticipated exceptions and their supply flexibility will help mitigate the adverse effects on U.S. ethane and propane sourcing.

    6. PE Exports
      Q: Will reduced U.S. polyethylene exports hurt supply?
      A: LYB is not a major exporter of polyethylene; strong domestic demand and robust customer relationships ensure that any reduction in exports will not significantly disrupt domestic supply.

    7. Circular Plastics
      Q: How are circular plastic volumes performing?
      A: Circular plastics have shown strong growth, expanding by over 57% annually, with steady interest from brand owners and ongoing investments in MoReTec initiatives supporting future demand.

    8. Metathesis Unit
      Q: Why proceed with the metathesis unit now?
      A: Despite added CapEx, the metathesis unit—embodied by Flex 2 with an IRR in the mid‐teens—fits LYB’s long‐term strategy by further upgrading the core business and reducing feedstock costs.

    9. China Outlook
      Q: What is the outlook for China capacity and licensing?
      A: Management noted that demand in China remains weak, with fewer new license requests, and that capacity expansions are slowing amid trade tensions and cautious economic stimulus.

    10. European Stimulus
      Q: Which products will benefit from European stimulus?
      A: The regulatory push in Europe is expected to favor circular products and bolster MoReTec investments, with the market anticipated to improve by 2026 as supportive measures take effect.